[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TNSN01115A1 - Composition en particules contenant de l'eletriptan, et procede pour sa production - Google Patents

Composition en particules contenant de l'eletriptan, et procede pour sa production

Info

Publication number
TNSN01115A1
TNSN01115A1 TNTNSN01115A TNSN01115A TNSN01115A1 TN SN01115 A1 TNSN01115 A1 TN SN01115A1 TN TNSN01115 A TNTNSN01115 A TN TNSN01115A TN SN01115 A TNSN01115 A TN SN01115A TN SN01115 A1 TNSN01115 A1 TN SN01115A1
Authority
TN
Tunisia
Prior art keywords
production
composition containing
particle composition
containing eletriptan
eletriptan
Prior art date
Application number
TNTNSN01115A
Other languages
English (en)
Inventor
Pierre Frederic De Raspide Manaud
James Macrae Ross
Walther Mathias
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN01115A1 publication Critical patent/TNSN01115A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)

Abstract

L'INVENTION CONCERNE UNE COMPOSITION PHARMACEUTIQUE SOUS FORME DE PARTICULES POUR L'ADMINISTRATION ORALE, COMPRENANT UN NOYAU CONTENANT DE L'ELETRIPTAN QUI EST REVETU D'UN ENROBAGE PERMEABLE INSOLUBLE DANS L'EAU. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE COMPOSITION DANS LE TRAITEMENT DE LA MIGRAINE ET LA PREVENTION DE LA RECURRENCE DE LA MIGRAINE.
TNTNSN01115A 2000-08-02 2001-08-01 Composition en particules contenant de l'eletriptan, et procede pour sa production TNSN01115A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition

Publications (1)

Publication Number Publication Date
TNSN01115A1 true TNSN01115A1 (fr) 2005-11-10

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01115A TNSN01115A1 (fr) 2000-08-02 2001-08-01 Composition en particules contenant de l'eletriptan, et procede pour sa production

Country Status (38)

Country Link
US (1) US20020034545A1 (fr)
EP (1) EP1365748B1 (fr)
JP (1) JP2004505034A (fr)
KR (1) KR20030024820A (fr)
CN (1) CN1630511A (fr)
AP (1) AP2001002233A0 (fr)
AR (1) AR030099A1 (fr)
AT (1) ATE308978T1 (fr)
AU (1) AU2001270932A1 (fr)
BG (1) BG107361A (fr)
BR (1) BR0112839A (fr)
CA (1) CA2417887C (fr)
CZ (1) CZ2003241A3 (fr)
DE (1) DE60114887T2 (fr)
EA (1) EA200300110A1 (fr)
EC (1) ECSP034451A (fr)
EE (1) EE200300051A (fr)
ES (1) ES2250429T3 (fr)
GB (1) GB0018968D0 (fr)
GT (1) GT200100149A (fr)
HR (1) HRP20030036A2 (fr)
HU (1) HUP0301453A2 (fr)
IL (1) IL153494A0 (fr)
IS (1) IS6649A (fr)
MA (1) MA26934A1 (fr)
MX (1) MXPA03000999A (fr)
NO (1) NO20030498D0 (fr)
NZ (1) NZ522976A (fr)
OA (1) OA12348A (fr)
PA (1) PA8523101A1 (fr)
PE (1) PE20020385A1 (fr)
PL (1) PL359847A1 (fr)
SK (1) SK1082003A3 (fr)
SV (1) SV2002000574A (fr)
TN (1) TNSN01115A1 (fr)
UY (1) UY26861A1 (fr)
WO (1) WO2002009675A1 (fr)
ZA (1) ZA200300868B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
EP1572107A1 (fr) * 2002-12-16 2005-09-14 CHX Technologies Inc. Enrobage dentaire temporaire pharmacologiquement inactif pour proteger "in situ" des agents therapeutiques dentaires de la salive et du frottement par mastication
CA2521902A1 (fr) * 2003-04-11 2004-10-21 Pfizer Inc. Combinaison pharmaceutique a base d'eletriptan et de bicarbonate de sodium
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (fr) * 2004-06-09 2005-12-22 Pfizer Limited Nouvelle formulation de l'eletriptan
WO2006013431A1 (fr) * 2004-07-29 2006-02-09 Pfizer Limited Formulation pharmaceutique stable à libération régulée d’eletriptan
EP1847268A1 (fr) * 2005-01-31 2007-10-24 Kyorin Pharmaceutical Co., Ltd. Preparation multidose a liberation prolongee pour administration par voie orale et procede de production de celle-ci
PL1915137T3 (pl) 2005-08-10 2014-03-31 Add Advanced Drug Delivery Tech Ltd Preparat doustny o kontrolowanym uwalnianiu
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ATE496623T1 (de) * 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
AU2008279087A1 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of HCV infection using same
WO2011057676A1 (fr) * 2009-11-16 2011-05-19 Evonik Röhm Gmbh Procédé de conversion d'un copolymère de (méth)acrylate solide en une forme dispersée au moyen d'un agent dispersant
JP2017527581A (ja) * 2014-09-09 2017-09-21 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
AP2001002233A0 (en) 2001-09-30
SV2002000574A (es) 2002-12-02
DE60114887D1 (de) 2005-12-15
NZ522976A (en) 2004-11-26
BG107361A (bg) 2003-06-30
AU2001270932A1 (en) 2002-02-13
OA12348A (en) 2004-03-19
GT200100149A (es) 2002-06-25
HRP20030036A2 (en) 2003-04-30
AR030099A1 (es) 2003-08-13
HUP0301453A2 (hu) 2003-08-28
KR20030024820A (ko) 2003-03-26
ES2250429T3 (es) 2006-04-16
MA26934A1 (fr) 2004-12-20
NO20030498L (no) 2003-01-31
PL359847A1 (pl) 2004-09-06
US20020034545A1 (en) 2002-03-21
IS6649A (is) 2002-12-05
JP2004505034A (ja) 2004-02-19
EP1365748B1 (fr) 2005-11-09
PA8523101A1 (es) 2002-08-26
CA2417887A1 (fr) 2002-02-07
WO2002009675A1 (fr) 2002-02-07
MXPA03000999A (es) 2003-06-09
EA200300110A1 (ru) 2003-06-26
EE200300051A (et) 2004-10-15
SK1082003A3 (en) 2004-09-08
UY26861A1 (es) 2002-02-28
ZA200300868B (en) 2004-04-16
WO2002009675A9 (fr) 2003-09-18
CN1630511A (zh) 2005-06-22
CZ2003241A3 (cs) 2004-02-18
IL153494A0 (en) 2003-07-06
BR0112839A (pt) 2003-06-24
ECSP034451A (es) 2003-03-10
EP1365748A2 (fr) 2003-12-03
PE20020385A1 (es) 2002-05-11
GB0018968D0 (en) 2000-09-20
ATE308978T1 (de) 2005-11-15
NO20030498D0 (no) 2003-01-31
DE60114887T2 (de) 2006-07-20
CA2417887C (fr) 2006-11-14

Similar Documents

Publication Publication Date Title
TNSN01115A1 (fr) Composition en particules contenant de l'eletriptan, et procede pour sa production
TNSN99073A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97139A1 (fr) Derives d'acides d'arylsulfonylaminohydroxamiques
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98022A1 (fr) DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
TNSN99110A1 (fr) Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
BE900563A (fr) Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.
BE1002109A3 (fr) Composition pharmaceutique a activite analgesique.
TNSN00169A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases, et compositions pharmaceutiques les contenant
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
BE904547A (fr) Nouveaux medicaments a usage topique.
TNSN00231A1 (fr) Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant
FR2787789B1 (fr) Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
HUP0104088A2 (hu) Késleltetett felszabadulású ranolazinkészítmények alkalmazása
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
TNSN98155A1 (fr) Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
TNSN97087A1 (fr) 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26586A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant